Biote Corp Net Worth
Biote Corp Net Worth Breakdown | BTMD |
Biote Corp Net Worth Analysis
Biote Corp's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Biote Corp's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Biote Corp's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Biote Corp's net worth analysis. One common approach is to calculate Biote Corp's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Biote Corp's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Biote Corp's net worth. This approach calculates the present value of Biote Corp's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Biote Corp's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Biote Corp's net worth. This involves comparing Biote Corp's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Biote Corp's net worth relative to its peers.
Enterprise Value |
|
To determine if Biote Corp is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Biote Corp's net worth research are outlined below:
| biote Corp had very high historical volatility over the last 90 days | |
| biote Corp has a poor financial position based on the latest SEC disclosures | |
| About 65.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from gurufocus.com: Biote Corp Q3 2024 Earnings Call Highlights Strong Revenue Growth and Strategic Enhancements |
Biote Corp Quarterly Good Will |
|
Biote Corp uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in biote Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Biote Corp's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 26th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Biote Corp's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Biote Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading biote Corp backward and forwards among themselves. Biote Corp's institutional investor refers to the entity that pools money to purchase Biote Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Northern Trust Corp | 2024-09-30 | 262.5 K | Jacobs Levy Equity Management, Inc. | 2024-06-30 | 218.1 K | Skylands Capital, Llc | 2024-09-30 | 198.5 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 197.9 K | Smh Capital Inc. | 2024-09-30 | 181 K | Renaissance Technologies Corp | 2024-09-30 | 163 K | Two Sigma Investments Llc | 2024-06-30 | 126.8 K | Millennium Management Llc | 2024-06-30 | 119.6 K | Bank Of New York Mellon Corp | 2024-06-30 | 94.3 K | 325 Capital Llc | 2024-09-30 | 4.5 M | Bandera Partners Llc | 2024-09-30 | 2.4 M |
Follow Biote Corp's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 323.88 M.Market Cap |
|
Project Biote Corp's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.02 | 0.02 | |
| Return On Capital Employed | 0.22 | 0.20 | |
| Return On Assets | 0.02 | 0.02 | |
| Return On Equity | (0.11) | (0.11) |
When accessing Biote Corp's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Biote Corp's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Biote Corp's profitability and make more informed investment decisions.
Please note, the presentation of Biote Corp's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biote Corp's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Biote Corp's management manipulating its earnings.
Evaluate Biote Corp's management efficiency
biote Corp has return on total asset (ROA) of 0.1816 % which means that it generated a profit of $0.1816 on every $100 spent on assets. This is way below average. Biote Corp's management efficiency ratios could be used to measure how well Biote Corp manages its routine affairs as well as how well it operates its assets and liabilities. As of November 22, 2024, Return On Tangible Assets is expected to decline to 0.02. In addition to that, Return On Capital Employed is expected to decline to 0.20. At present, Biote Corp's Non Currrent Assets Other are projected to decrease significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 1.25, whereas Net Tangible Assets are projected to grow to (42.3 M).| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (1.42) | (1.49) | |
| Tangible Book Value Per Share | (1.61) | (1.70) | |
| Enterprise Value Over EBITDA | 16.56 | 17.38 | |
| Price Book Value Ratio | (4.32) | (4.10) | |
| Enterprise Value Multiple | 16.56 | 17.38 | |
| Price Fair Value | (4.32) | (4.10) | |
| Enterprise Value | 152.9 M | 83.7 M |
biote Corp has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Enterprise Value Revenue 1.425 | Revenue 193.1 M | Quarterly Revenue Growth 0.128 | Revenue Per Share 5.767 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Biote Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Biote Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Biote Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Biote Corp Corporate Filings
| 13th of November 2024 Other Reports | ViewVerify | |
13A | 12th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
13A | 22nd of October 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
F4 | 11th of September 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Biote Corp Earnings per Share Projection vs Actual
Biote Corp Corporate Management
| Teresa Weber | CEO Director | Profile | |
| Samar Kamdar | Principal CFO | Profile | |
| Ross MD | Chief Officer | Profile | |
| Jennifer Schimmel | Director Talent | Profile | |
| James II | Chief Officer | Profile | |
| Robert Peterson | Chief Officer | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in biote Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Biote Stock refer to our How to Trade Biote Stock guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biote Corp. If investors know Biote will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biote Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.375 | Earnings Share 0.3 | Revenue Per Share 5.767 | Quarterly Revenue Growth 0.128 | Return On Assets 0.1816 |
The market value of biote Corp is measured differently than its book value, which is the value of Biote that is recorded on the company's balance sheet. Investors also form their own opinion of Biote Corp's value that differs from its market value or its book value, called intrinsic value, which is Biote Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biote Corp's market value can be influenced by many factors that don't directly affect Biote Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biote Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biote Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biote Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.